Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Sunshine Biopharma Inc. (SBFM)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 18, 2026 | CORRESP | Neutral/Informational | Moderate | Sunshine Biopharma Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, seeking to have it effective by 1… | Read Filing EDGAR |
| May. 18, 2026 | CORRESP | Neutral/Informational | Moderate | The correspondence from Aegis Capital Corp. to the SEC requests the acceleration of the effective date for Sunshine Biopharma Inc.'s Registration Statement No. 333-295800 to May 1… | Read Filing EDGAR |
| May. 14, 2026 | CORRESP | Neutral/Informational | Moderate | Sunshine Biopharma Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. They are seeking to have the stat… | Read Filing EDGAR |
| May. 14, 2026 | CORRESP | Neutral/Informational | Moderate | Sunshine Biopharma Inc. has submitted a request for the acceleration of the effective date of their Registration Statement No. 333-295800 on Form S-1. The request is made under Ru… | Read Filing EDGAR |
| May. 4, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence informs Sunshine Biopharma Inc. that they do not intend to review the company's draft registration statement submitted on April 28, 2026. The SEC requests t… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.